Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2020-05-22 / Immunotargets Ther 2020;9:95-104Feasibility of modulated electro-hyperthermia in preoperative treatment for locally advanced rectal cancer: Early phase 2 clinical results
/in Colorectal Cancer, Hyperthermia, International Publications /von 2020-02-09 / Neoplasma 2020 May;67(3):677-683Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2019-10-03 / Cancers (Basel) 2019 Oct;11(10)Application of Newcastle disease virus in the treatment of colorectal cancer
/in Colorectal Cancer, International Publications, Newcastle Disease Virus /von 2019-08-26 / World J Clin Cases 2019 Aug;7(16):2143-2154Modulated electro-hyperthermia induced p53 driven apoptosis and cell cycle arrest additively support doxorubicin chemotherapy of colorectal cancer in vitro
/in Colorectal Cancer, Hyperthermia, International Publications /von 2019-06-10 / Cancer Med 2019 Jun;Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer
/in Colorectal Cancer, Gastric Cancer, International Publications, Micronutrients /von 2019-05-16 / 2019 May;19(1):460Dendritic cell vaccine with Ag85A enhances anti-colorectal carcinoma immunity
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2018-10-11 / Exp Ther Med 2018 Dec;16(6):5123-5129A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2018-09-29 / J Immunother Cancer 2018 Sep;6(1):96Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour
/in Colorectal Cancer, International Publications, Micronutrients /von 2018-09-13 / 2018 11;103:98-107
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de